logo
Hovering over the toilet? You may be hurting your bladder

Hovering over the toilet? You may be hurting your bladder

Time of India5 days ago
New Delhi: Hovering over public toilets to avoid germs may seem hygienic, but doctors warn it can harm your bladder. The half-squat position often adopted by women prevents full bladder emptying, increasing the risk of urine retention, urinary tract infections (UTIs) and long-term pelvic floor issues.
"It causes increased bladder pressure and can raise the risk of UTIs, bladder irritation, and even long-term problems," said Dr Nikhil Khattar, associate director, urology, PSRI Hospital.
He explained that when this posture is used regularly, it trains the body into a habit of incomplete urination. This affects how the bladder muscles function, and may eventually cause symptoms like frequent urgency, leakage or difficulty emptying the bladder fully.
You Can Also Check:
Delhi AQI
|
Weather in Delhi
|
Bank Holidays in Delhi
|
Public Holidays in Delhi
"Retained urine also provides a good environment for bacteria to grow, which increases the chance of recurrent UTIs and, in some cases, even kidney infections," he said.
The risks are similar when people delay urinating for too long, which many do in public places to avoid using unclean restrooms. "Whether you are holding your urine or not sitting properly while passing it, both habits harm the pelvic floor muscles and interfere with normal bladder emptying," Dr Khattar added.
Dr Neelam Suri, senior consultant in obstetrics and gynaecology at Indraprastha Apollo Hospitals, said the full squat position — as used with traditional Indian toilets — is much healthier. "In a full squat, the pelvic muscles relax fully, making it easier to empty both the bladder and bowel," she said. "Half-squatting or hovering keeps the muscles tense and doesn't allow proper urination."
According to her, many women hover over Western-style toilets out of fear of infection.
But the posture itself can do more harm in the long run. "Studies suggest that hovering increases the risk of incomplete urination and pelvic strain, which can lead to chronic issues," she added.
Dr Gaurav Garg, senior consultant, urology, Max Smart Hospital, Saket, also said long-term half-squatting can contribute to pelvic floor dysfunction and stress incontinence — where urine leaks out during coughing, sneezing or physical activity.
"Many women who come to us with these issues don't realise it's linked to their posture during urination," he said.
Doctors also clarified a common myth: simply sitting on a public toilet seat doesn't directly cause UTIs. "UTIs are primarily caused by bacteria like E. coli entering the urethra and multiplying in the urinary tract," said Dr Khattar. "Poor hygiene, improper wiping, touching contaminated surfaces or not washing hands properly are bigger risks.
The toilet seat itself is rarely the cause."
D
r Atul Goswami, director of urology and uro-oncology at Sri Balaji Action Medical Institute, said awareness is key and women should feel empowered to sit properly by using tools like disposable seat covers or toilet seat sanitisers when using public toilets. "Touching the seat is not as dangerous as incomplete urination, which can cause real and lasting harm," he said.
Experts stressed the need to educate women about proper toilet habits and break the widespread fear around public toilet seats. "We must spread the message that sitting properly and emptying the bladder fully is essential for good urinary health," said Dr Suri.
In a country where access to clean public toilets remains a challenge, doctors say small changes — like carrying hygiene products and choosing to sit instead of hover — can help protect long-term health. What feels like a quick fix may be doing silent damage, and the best choice might just be the one that feels most uncomfortable: sitting down.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Breakthrough In Liver Cirrhosis Treatment: Indian Scientists Develop New Approach
Breakthrough In Liver Cirrhosis Treatment: Indian Scientists Develop New Approach

India.com

time12 minutes ago

  • India.com

Breakthrough In Liver Cirrhosis Treatment: Indian Scientists Develop New Approach

New Delhi: A team of Indian scientists has found a new way to treat liver cirrhosis, by targeting the lymphatic vessels in the liver and intestine that fail in case of cirrhosis. Chronic liver disease can progress from mild disease to fibrosis to cirrhosis (also known as scarring). Cirrhosis is accompanied by the distortion of both blood and lymphatic vessels in the liver and the intestine. Patients with advanced cirrhosis often develop complications like fluid accumulation in the abdomen. A team of scientists from the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, focussed on improving the drainage capacity of lymphatic vessels in the liver and intestine by using nanocarriers filled with a powerful protein called VEGF-C. Pic Credits: IANS 'Vascular endothelial growth factor-C (VEGF-C) is a key pro-lymphangiogenic factor that activates lymphangiogenesis or new lymphatic vessel growth. It does this through binding to a cell membrane tyrosine kinase receptor, vascular endothelial growth factor receptor-3 (VEGFR-3), the activation of which is essential for the growth and development of new lymphatic vessels,' said the researchers. The team probed the therapeutic efficacy of VEGF-C in ameliorating gut lymphatic dysfunction and improving lymph drainage. Owing to the hydrophilicity, short half-life, and systemic side effects of VEGF-C, the team led by Dr Subham Banerjee from NIPER Guwahati first focused on the development of VEGF-C encapsulated reverse micelle-based nanocarriers, which specifically bind to VEGFR-3 homodimers. Next, the ILBS team, led by Dr Savneet Kaur, tested the developed VEGF-C nanocarriers extensively in animal models of advanced cirrhosis and portal hypertension. The developed molecule was delivered via the oral route to ensure its gut lymphatic vessel uptake in the animal models. The team showed that VEGF-C nanocarriers significantly increased mesenteric lymph drainage, which reduced ascites. Importantly, the treatment also led to an attenuation of the portal pressures, improved cytotoxic T-cell immunity in mesenteric lymph nodes, and reduced local and systemic bacterial load. The research, published in the JHEP Reports journal, is the first to highlight that therapeutic lymphangiogenesis with VEGF-C is a promising treatment for reconstructing the fragmented lymphatic network and restoring lymphatic function and drainage in advanced cirrhosis.

AIIMS-led study shows two-medicine combination therapy effective in controlling high BP
AIIMS-led study shows two-medicine combination therapy effective in controlling high BP

Hans India

time42 minutes ago

  • Hans India

AIIMS-led study shows two-medicine combination therapy effective in controlling high BP

Using a single pill comprising two blood pressure medicines is a safe and highly effective way to treat hypertension among South Asians, particularly Indians, finds a study led by the All India Institute of Medical Sciences (AIIMS), New Delhi. The study, in partnership with the Centre for Chronic Disease Control (CCDC) and Imperial College London, UK, compared three widely used drug combinations: amlodipine plus perindopril, amlodipine plus indapamide, and perindopril plus indapamide. The first randomised trial to test three different two-drug combination pills among South Asians involved over 1,200 patients with uncontrolled hypertension across 32 hospitals in India. 'All three combinations worked equally well in reducing blood pressure and were safe for patients,' revealed the study, published in the journal Nature Medicine. The findings showed that either of the two-drug combinations led to a significant drop in blood pressure after 6 months -- by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings. 'Nearly 70 per cent of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care,' said Dr Ambuj Roy, Professor of Cardiology at AIIMS Delhi. 'This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients,' said Dr Dorairaj Prabhakaran, Executive Director of CCDC. High blood pressure (hypertension) is the leading risk factor for death worldwide and affects over 300 million people in India alone. Treating it early and effectively can prevent heart attacks, strokes, and kidney failure. Doctors often recommend starting with two medications in one pill to control blood pressure better and help patients stick to treatment. But until now, no large study had tested which combinations worked best for South Asians, who make up a quarter of the world's population. The results revealed that nearly 70 per cent of patients with any of the dual drug therapy reached the recommended blood pressure target of below 140/90 mmHg -- five times higher than India's current average control rate. Less than 3 per cent of patients reported side effects serious enough to stop treatment. 'These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country,' Prabhakaran said.

Health experts urge govt to mandate dengue reporting
Health experts urge govt to mandate dengue reporting

Hans India

time2 hours ago

  • Hans India

Health experts urge govt to mandate dengue reporting

Hyderabad: Health experts are urging the government to establish a mechanism that ensures hospitals report dengue complications. They also suggest that protocol-based treatment should be encouraged through knowledge-sharing between tertiary centres and rural areas to prevent deaths and huge expenditures. As dengue is a seasonal, epidemic disease, complications often require tertiary centre monitoring. From prevention to updating protocol-based treatment, a new approach is urgently needed for this tropical disease. Dr Madap Karuna, a consultant at EMRI Green Health Services, said that since dengue is a tropical disease, the cases may not be the same in Western countries, and therefore they may not have case studies of severe cases. 'There is a WHO protocol where we get to know not much about severe dengue management. The protocols have not been updated for severe cases,' said Dr Karuna. 'The policymakers also should know that the medical field is evolving; there are new diseases. During COVID, everybody was doing research and they gave a lot of options. Now, dengue is also changing patterns, as there are severe complications. Multi-centric studies should be encouraged by policymakers. We should give our data to WHO so that every doctor should know how to tackle it.' The issue doctors face with dengue cases is that patients are often brought to the hospital in a bad state. Doctors said that in this scenario, if there is already a publication or knowledge-sharing of experiences, the feedback can be helpful for patient treatment. The private sector has been making some effort through conferences at a nominal price, but there is no such mechanism from the rural centres, doctors noted. Doctors point out a rise in the number of dengue cases until September-October and therefore want the government to initiate awareness campaigns. Dr Karuna said that dengue has existed for two decades and people should know when to refer a patient, what type of treatment can be provided, etc. Similarly, the cost of treatments is also pushing patients into poverty. 'Once a child is in hospital, it is very difficult to manage,' said Dr Karuna. Senior cardiologist and faculty at the International Training Center at Gandhi Medical College, Dr Vijay Rao, said that while protocols and guidelines do exist in every field of medicine, sometimes it is practical common sense that helps in clinical medicine, especially in developing countries where resources are scarce.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store